Gold Nanoparticles Regulate Gut Microbiota and Immune Responses for Overcoming Iron Supplementation Side Effects in Anemia Therapy

Iron deficiency anemia (IDA) is a common nutritional deficiency disease caused by iron deficiency. Oral iron supplementation, the simplest and most commonly used iron repletion strategy in the clinic, primarily induces gastrointestinal inflammation, which subsequently elicits complications, including nausea, gastrointestinal bleeding, and constipation. Oral iron supplementation, the most simple and widespread method of iron replenishment in the clinic, primarily causes gastrointestinal inflammation, which, in turn, leads to complications such as nausea, gastrointestinal bleeding, and constipation. Furthermore, gastrointestinal inflammation impedes the absorption of iron, thereby exacerbating anemia. Gold nanoparticles with an inherent anti-inflammatory effect make them a promising weapon for alleviating iron-induced gut inflammation. Herein, we studied the effects of 4,6-diamino-2-pyrimidinethiol (DAPT)-functionalized gold nanoparticles (DAu NPs) on the iron supplementation efficiency and gut inflammation in the IDA model. We discussed the mechanisms of gut microbiota and immune responses on gut inflammation using the 16S rRNA (rRNA) gene sequencing and the polarization of RAW 264.7 cells <i>in vitro</i>. DAu NPs with oral iron supplementation could effectively treat IDA. DAu NPs played a significant role in reshaping gut microbiota, promoting short-chain fatty acid production, and regulating immune responses to reduce inflammation caused by excess iron. <i>In vitro</i>, DAu NPs could inhibit iron-dependent bacteria (<i>Escherichia coli</i>) proliferation while promoting probiotic (<i>Lactobacillus</i>) growth. Oral administration of DAu NPs could regulate M2 polarization of gut macrophages, reduce neutrophil and Th17 cell infiltration, and increase Treg cells recruitment. DAu NPs accumulated primarily in the colon and were excreted via feces, demonstrating excellent biosafety. Our study provides a potential method for the treatment of IDA and other metal element deficiencies.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-03-12
DOI
https://doi.org/10.1021/acsnano.6c02349
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gold Nanoparticles Regulate Gut Microbiota and Immune Responses for Overcoming Iron Supplementation Side Effects in Anemia Therapy

Huize Luo, Pai Zhang, Wenshuai Hao, Y. Y. Ji et al.
ACS Nano
Iron Metabolism and Disorders
article

Gold Nanoparticles Regulate Gut Microbiota and Immune Responses for Overcoming Iron Supplementation Side Effects in Anemia Therapy

Huize Luo, Pai Zhang, Wenshuai Hao, Y. Y. Ji, Yanxue Si, Qianqian Lin, Ruitao Cha, Chenyan Li, Xiaohui Wang, Chunliang Zhang
article en

Abstract

Iron deficiency anemia (IDA) is a common nutritional deficiency disease caused by iron deficiency. Oral iron supplementation, the simplest and most commonly used iron repletion strategy in the clinic, primarily induces gastrointestinal inflammation, which subsequently elicits complications, including nausea, gastrointestinal bleeding, and constipation. Oral iron supplementation, the most simple and widespread method of iron replenishment in the clinic, primarily causes gastrointestinal inflammation, which, in turn, leads to complications such as nausea, gastrointestinal bleeding, and constipation. Furthermore, gastrointestinal inflammation impedes the absorption of iron, thereby exacerbating anemia. Gold nanoparticles with an inherent anti-inflammatory effect make them a promising weapon for alleviating iron-induced gut inflammation. Herein, we studied the effects of 4,6-diamino-2-pyrimidinethiol (DAPT)-functionalized gold nanoparticles (DAu NPs) on the iron supplementation efficiency and gut inflammation in the IDA model. We discussed the mechanisms of gut microbiota and immune responses on gut inflammation using the 16S rRNA (rRNA) gene sequencing and the polarization of RAW 264.7 cells <i>in vitro</i>. DAu NPs with oral iron supplementation could effectively treat IDA. DAu NPs played a significant role in reshaping gut microbiota, promoting short-chain fatty acid production, and regulating immune responses to reduce inflammation caused by excess iron. <i>In vitro</i>, DAu NPs could inhibit iron-dependent bacteria (<i>Escherichia coli</i>) proliferation while promoting probiotic (<i>Lactobacillus</i>) growth. Oral administration of DAu NPs could regulate M2 polarization of gut macrophages, reduce neutrophil and Th17 cell infiltration, and increase Treg cells recruitment. DAu NPs accumulated primarily in the colon and were excreted via feces, demonstrating excellent biosafety. Our study provides a potential method for the treatment of IDA and other metal element deficiencies.

ACS NanoVol. 20(11)
Center for NanoScience (DE), Southern University of Science and Technology (CN), China University of Geosciences (Beijing) (CN), National Center for Nanoscience and Technology (CN)
Zero hunger
Openalex Percentile: Top 23%
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.